2025-04-13 15:50:40
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Ganesh Benzoplast Ltd Q2FY21 consolidated PAT at Rs. 9.55 crore
Posted On : 2020-11-14 00:00:58( TIMEZONE : IST )
GANESH BENZOPLAST LTD. has reported financial results for the period ended March 31, 2020.
Financial Results (Q4 FY19-20) - QoQ Comparison
The company has reported total income of Rs.54.58 crores during the period ended March 31, 2020 as compared to Rs.51.96 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.9.55 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.14.27 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.1.84 for the period ended March 31, 2020 as compared to Rs.2.76 for the period ended December 31, 2019.
| Financials | Q4 FY19-20 | Q3 FY19-20 | % Change |
| Total Income | ₹ 54.58 crs | ₹ 51.96 crs |  5.04% |
| Net Profit | ₹ 9.55 crs | ₹ 14.27 crs |  -33.08% |
| EPS | ₹ 1.84 | ₹ 2.76 | -33.33% |
Financial Results (Q4 FY19-20) - YoY Comparison
The company has reported total income of Rs.54.58 crores during the period ended March 31, 2020 as compared to Rs.50.33 crores during the period ended March 31, 2019.
The company has posted net profit / (loss) of Rs.9.55 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.8.94 crores for the period ended March 31, 2019.
The company has reported EPS of Rs.1.84 for the period ended March 31, 2020 as compared to Rs.1.73 for the period ended March 31, 2019.
| Financials | Q4 FY19-20 | Q4 FY18-19 | % Change |
| Total Income | ₹ 54.58 crs | ₹ 50.33 crs | 8.44% |
| Net Profit | ₹ 9.55 crs | ₹ 8.94 crs | 6.82% |
| EPS | ₹ 1.84 | ₹ 1.73 | 6.36% |
Financial Results (12 months ended FY 19-20) - YoY Comparison
The company has reported total income of Rs.106.55 crores during the 6 months period ended March 31, 2020 as compared to Rs.118.97 crores during the 6 months period ended March 31, 2019.
The company has posted net profit / (loss) of Rs.23.83 crores for the 6 months period ended March 31, 2020 as against net profit / (loss) of Rs.15.35 crores for the 6 months period ended March 31, 2019.
The company has reported EPS of Rs.4.60 for the 6 months period ended March 31, 2020 as compared to Rs.2.96 for the 6 months period ended March 31, 2019.
| Financials | Year Ended FY19-20 | Year Ended FY18-19 | % Change |
| Total Income | ₹ 106.55 crs | ₹ 118.97 crs | -10.44% |
| Net Profit | ₹ 23.83 crs | ₹ 15.35 crs | 55.24% |
| EPS | ₹ 4.60 | ₹2.96 | 55.41% |
The profit was impacted due to increase in finance cost to the tune of Rs. 22.59 Mn. in the current quarter is on account of payment of long disputed interest to creditors of chemical division. There was also exceptional expenses to the tune of Rs. 1.60 crore pertaining to the Chemical division. The profit was also impacted as the company started providing for tax of Rs. 3.22 crore in Q2FY21.
Shares of GANESH BENZOPLAST LTD. was last trading in BSE at Rs.69.15 as compared to the previous close of Rs. 66.75. The total number of shares traded during the day was 222539 in over 724 trades.
The stock hit an intraday high of Rs. 70 and intraday low of 65.95. The net turnover during the day was Rs. 15245861.
